Form 4: MindMed CLO Sells Shares for Tax Obligations

Mind Medicine's Chief Legal Officer, Mark Sullivan, sold 11,276 common shares on December 26, 2025, to cover tax obligations from vested restricted stock units.

Summary

• Mark Sullivan, Chief Legal Officer of Mind Medicine (MindMed) Inc. (MNMD), reported a transaction on December 26, 2025.
• Sullivan sold 11,276 common shares at a weighted average price of $13.1469 per share.
• The sale was executed to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units.
• This transaction was conducted pursuant to a Rule 10b5-1 plan adopted on March 14, 2024.
• Following the sale, Sullivan directly beneficially owns 282,576 common shares.
• The shares were sold in multiple transactions at prices ranging from $13.02 to $13.33.

Sentiment

Score: 5

Explanation: The transaction is a routine sell-to-cover for tax obligations, indicating no specific positive or negative sentiment regarding the company's performance or outlook. It is a neutral event.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 plan, indicating a planned and routine event rather than a discretionary sale based on new information.
• The sale was specifically for 'sell-to-cover' tax obligations, which is a common practice for executives receiving equity compensation and does not necessarily reflect a lack of confidence in the company.

Negatives

• No inherent negatives are identified from this routine, tax-related insider transaction.

Future Outlook

This Form 4 filing, detailing an insider transaction, does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, particularly 'sell-to-cover' sales for tax purposes, are a common occurrence across all industries for executives receiving equity-based compensation. This specific transaction aligns with typical executive compensation practices and Rule 10b5-1 plan usage.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, pre-planned tax-related sale by an insider, not indicative of a change in company fundamentals or insider confidence.

Key Dates

Recommendation

The sale by the Chief Legal Officer is a routine 'sell-to-cover' transaction to satisfy tax obligations related to vested restricted stock units, executed under a pre-arranged Rule 10b5-1 plan. This type of transaction is not indicative of a change in the company's fundamentals or the insider's confidence in the company, and therefore does not warrant a change from a 'hold' recommendation based solely on this filing.

Keywords

Mind Medicine, MNMD, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Obligations, Rule 10b5-1, Executive Compensation